
Rithika Pharmaceuticals Private Limited
About Rithika Pharmaceuticals Private Limited
Data last updated:
Rithika Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the diversified business activities segment of the business services sector. It was incorporated on 15 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC122261.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Gandupalli Eswari and Srinivasa Rao Gandupalli.
Its last annual general meeting (AGM) was held on 21 October 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at H. No. 9 – 2 Temple Alwal Above Scanda Medicals, Hyderabad, Telangana, India – 500010.
As per the financials filed for FY 2019, the company reported a revenue of ₹21.68 Lakh. For the same year it recorded a net loss of ₹1.24 Lakh (net margin -5.7%) and EBITDA of -₹44,125 (EBITDA margin -2%).
Company details
Recognitions & Rankings of Rithika Pharmaceuticals
Contact details
Rithika Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressH. No. 9 – 2 Temple Alwal Above Scanda Medicals, Hyderabad, Telangana, India – 500010
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rithika Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rithika Pharmaceuticals Private Limited, buy the company report.
Financials of Rithika Pharmaceuticals Private Limited
FY 2019 filings availableRithika Pharmaceuticals Private Limited reported revenue of ₹21.68 Lakh for FY 2019.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹44,125 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.24 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -2% | |
| Net Profit Margin | -5.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rithika Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rithika Pharmaceuticals Private Limited
Rithika Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gandupalli Eswari Also directs: Sree Rithika Laboratories Private Limited | Director | 16 Aug 2019 | 7 Years 2 Months | Current |
| Srinivasa Rao Gandupalli Also directs: Sree Rithika Laboratories Private Limited | Director | 15 Feb 2018 | 8 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Rithika Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rithika Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rithika Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rithika Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Srinivasa Chary Bairoju ceased to be Director on 19 Aug 2019.
Frequently asked questions
Rithika Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 15 February 2018 (8+ years old) and is registered under CIN U74999TG2018PTC122261.
Rithika Pharmaceuticals has 2 current directors:
- Gandupalli Eswari - Director
- Srinivasa Rao Gandupalli - Director
The latest financial statements of Rithika Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 21 October 2019. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Rithika Pharmaceuticals is U74999TG2018PTC122261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rithika Pharmaceuticals was incorporated on 15 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Srinivasa Chary Bairoju ceased to be Director on 19 Aug 2019. Gandupalli Eswari was appointed as Director on 16 Aug 2019. Srinivasa Chary Bairoju was appointed as Director on 15 Feb 2018. Rithika Pharmaceuticals has 4 board changes on record in total.
Yes, Rithika Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Rithika Pharmaceuticals is at H. No. 9 – 2 Temple Alwal Above Scanda Medicals, Hyderabad, Telangana, India – 500010.
Rithika Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
Rithika Pharmaceuticals can be reached at its registered office: H. No. 9 – 2 Temple Alwal Above Scanda Medicals, Hyderabad, Telangana, India – 500010.

